(HealthDay)—Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy, according to a study published ...
Aug 24, 2021
0
37
Since antiretroviral therapy (ART) for HIV was introduced in 1996, AIDS-related morbidity and mortality has declined significantly. People living with HIV are now expected to live nearly as long as people without HIV. Despite ...
Jul 21, 2021
1
138
A presentation at this year's European Congress on Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, will discuss the growing evidence that the beta SARS-CoV-2 variant first identified in South ...
Jul 10, 2021
1
194
New annual infections with HIV fell by 73 percent from its peak in the mid-1980s to 2019, according to a new analysis by US health authorities released Thursday.
Jun 4, 2021
0
10
Forty years on since the first AIDS cases were reported, the United Nations said Thursday it was cautiously optimistic that the human immunodeficiency virus (HIV)—the virus that causes the disease—could be beaten by 2030.
Jun 3, 2021
0
2
In a new feature in the New England Journal of Medicine, Michael Saag, M.D., professor with the University of Alabama at Birmingham Division of Infectious Diseases and director of the UAB Center for AIDS Research, details ...
Jun 3, 2021
0
0
While the risk of hepatocellular carcinoma (HCC) – primary liver cancer—is higher among patients who have HIV, it's even higher among patients who have HIV and detectable hepatitis B, according to research from the Perelman ...
May 21, 2021
0
10
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) and Yale University have succeeded in reducing the size of the HIV reservoir in humanized mice by using a "molecular can opener" and a combination ...
May 20, 2021
0
4861
People living with human immunodeficiency virus (HIV) and without known cardiovascular disease have two to three times the noncalcified coronary plaque burden of non-HIV healthy volunteers, according to a study from Canada ...
Apr 20, 2021
0
8
Researchers at the Indian Institute of Science (IISc) have developed artificial enzymes that can successfully block reactivation and replication of the Human Immunodeficiency Virus (HIV) in the host's immune cells.
Apr 1, 2021
0
4
